Using the “reverse Warburg effect” to identify high-risk breast cancer patients: Stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers

Witkiewicz, Agnieszka K., Whitaker-Menezes, Diana, Dasgupta, Abhijit, Philp, Nancy J., Lin, Zhao, Gandara, Ricardo, Sneddon, Sharon, Martinez-Outschoorn, Ubaldo E. +2 more·2012·Cell Cycle

Cited by (241)

Items 101–200 of 241

  1. Autophagic tumor stroma: Mechanisms and roles in tumor growth and progression
    Xianda Zhao, Yuyu He, Honglei Chen · 2012 · International Journal of Cancer
  2. Monocarboxylate Transporter 1 Inhibitors as Potential Anticancer Agents
    Shirisha Jonnalagadda, Sravan K. Jonnalagadda, Mohammad Abrar Alam, Grady L. Nelson, Mary Sneve, Lester R. Drewes, Venkatram R. Mereddy · 2015 · ACS Medicinal Chemistry Letters
  3. Molecular Pathways: Preclinical Models and Clinical Trials with Metformin in Breast Cancer
    Alastair Mark Thompson · 2014 · Clinical Cancer Research
  4. Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics
    Soumik Pal, Amit Kumar Sharma, Sam Padalumavunkal Mathew, Bithiah Grace Jaganathan · 2022 · Frontiers in Immunology
  5. Contribution of adipocytes in the tumor microenvironment to breast cancer metabolism
    Xiaodan Lyu, Qian Zhang, Hamza M. Fares, Yifan Wang, Yi Han, Li Sun · 2022 · Cancer Letters
  6. Metabolic control analysis of cellular respiration in situ in intraoperational samples of human breast cancer
    Tuuli Käämbre, Vladimir A. Chekulayev, Igor N. Shevchuk, Minna Karu-Varikmaa, Natalja Timohhina, Kersti Tepp, Jelena Bogovskaja, Riina Kütner, Vahur Valvere, Valdur A. Saks · 2012 · Journal of Bioenergetics and Biomembranes
  7. Composite analysis of immunological and metabolic markers defines novel subtypes of triple negative breast cancer
    Thomas A Adams, Paris J. Vail, Amanda Ruiz, Mehri Mollaee, Peter A. McCue, Erik S. Knudsen, Agnieszka Katarzyna Witkiewicz · 2017 · Modern Pathology
  8. Cancer-associated fibroblast senescence and its relation with tumour-infiltrating lymphocytes and PD-L1 expressions in intrahepatic cholangiocarcinoma
    Chuan Lan, Yuki Kitano, Yo‐ichi Yamashita, Takanobu Yamao, Kiyoshi Kajiyama, Tomoharu Yoshizumi, Kengo Fukuzawa, Keishi Sugimachi, Yasuharu Ikeda, Hiroshi Takamori et al. · 2021 · British Journal of Cancer
  9. Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer
    Gyöngyi Munkácsy, Libero Santarpia, Balázs Győrffy · 2023 · International Journal of Molecular Sciences
  10. Epigallocatechin‑3‑gallate hinders metabolic coupling to suppress colorectal cancer malignancy through targeting aerobic glycolysis in cancer‑associated fibroblasts
    Shuhai Chen, Masaaki Nishi, Yuji Morine, Mitsuo Shimada, Takuya Tokunaga, Hideya Kashihara, Chie Takasu, Shinichiro Yamada, Yuma Wada · 2022 · International Journal of Oncology
  11. Identification of key binding site residues of MCT1 for AR-C155858 reveals the molecular basis of its isoform selectivity
    Bethany Nancolas, Richard Barry Sessions, Andrew P. Halestrap · 2014 · Biochemical Journal
  12. Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents
    Shirisha Jonnalagadda, Sravan K. Jonnalagadda, Mohammad Abrar Alam, Conor T. Ronayne, Grady L. Nelson, Lucas N. Solano, Erica A. Lueth, Lester R. Drewes, Venkatram R. Mereddy · 2016 · Bioorganic & Medicinal Chemistry Letters
  13. Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: Key events in the progression from an in situ to an invasive breast carcinoma
    Diana F. Martins, Francisco Ferro de Beça, Bárbara Sousa, Fátima Baltazar, Joana Paredes, Fernando Carlos Schmitt · 2013 · Cell Cycle
  14. Compartment-specific activation of PPARγ governs breast cancer tumor growth, via metabolic reprogramming and symbiosis
    Paola Avena, Wanda Anselmo, Chenguang Wang, Richard G. Pestell, Rebecca Lamb, Ivan Casaburi, Sebastiano Andò, Ubaldo Martinez‐Outschoorn, Michael P. Lisanti · 2013 · Cell Cycle
  15. 3D bioprinting and the revolution in experimental cancer model systems—A review of developing new models and experiences with in vitro 3D bioprinted breast cancer tissue-mimetic structures
    Dániel Sztankovics, Dorottya Moldvai, Gábor Petővári, Rebeka Gelencsér, Ildikó Krencz, Regina Eszter Raffay, Titanilla Dankó, Anna Réka Sebestyén · 2023 · Pathology & Oncology Research
  16. Shikonin blocks CAF-induced TNBC metastasis by suppressing mitochondrial biogenesis through GSK-3β/NEDD4-1 mediated phosphorylation-dependent degradation of PGC-1α
    Shuangqin Fan, Xiaomin Yan, Xiaoxia Hu, Xing Liu, Shijie Zhao, Yue Zhang, Xiaofeng Zhou, Xiangchun Shen, Qi Qi, Yan Chen · 2024 · Journal of Experimental & Clinical Cancer Research
  17. Targeting Metabolic Cross Talk between Cancer Cells and Cancer-Associated Fibroblasts
    Jin Gyoung Jung, Anne Le · 2018 · Advances in experimental medicine and biology
  18. Metabolic cooperation between cancer and non-cancerous stromal cells is pivotal in cancer progression
    Filipa Lopes‐Coelho, Sofia Gouveia-Fernandes, Jacinta Serpa · 2018 · Tumor Biology
  19. Impaired mitochondrial protein synthesis in head and neck squamous cell carcinoma
    Emine C. Koc, Ebru Hacıosmanoğlu, Pier Paolo Claudio, Allison Wolf, Luigi Califano, Marco Friscia, Antonio Cortese, Hasan Koç · 2015 · Mitochondrion
  20. Intratumoral lactate metabolism in Barrett's esophagus and adenocarcinoma
    Heikki I. Huhta, Olli Helminen, Sami Palomäki, Joonas H. Kauppila, Juha Saarnio, Petri P Lehenkari, Tuomo J. Karttunen · 2017 · Oncotarget
  21. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes
    László Bányai, Mária Trexler, Krisztina Kerekes, Orsolya Csuka, László Patthy · 2021 · eLife
  22. Advancement in precision diagnosis and therapeutic for triple-negative breast cancer: Harnessing diagnostic potential of CRISPR-cas & engineered CAR T-cells mediated therapeutics
    Vinayak Nayak, Sushmita Patra, Kshitij RB Singh, Bristy Ganguly, Das Nishant Kumar, Deepak Panda, Ganesh Kumar Maurya, Jay Singh, Sanatan Majhi, Rohit Sharma et al. · 2023 · Environmental Research
  23. Exosomes: a double‐edged sword in cancer immunotherapy
    Jiayi Chen, Siyuan Hu, Jiayi Liu, Hao Jiang, Simiao Wang, Zhaogang Yang · 2025 · MedComm
  24. Lactate: elucidating its indispensable role in human health
    Shengxin Zhang, Jie Wang, Ziyu Xu, Ziyang Cheng, Bin Shao, Jiayun Yu · 2026 · Molecular Cancer
  25. Targeting breast cancer initiating cells: Advances in breast cancer research and therapy
    James Andrew McCubrey, Nicole M. Davis, Stephen Lee Abrams, Giuseppe Montalto, Melchiorre Cervello, Massimo Libra, Ferdinando Nicoletti, Antonino B. D’Assoro, Lucio Cocco, Alberto Maria Martelli et al. · 2014 · Advances in Biological Regulation
  26. Mitochondrial Respiration in Human Colorectal and Breast Cancer Clinical Material Is Regulated Differently
    Andre Koit, Igor N. Shevchuk, Lyudmila Ounpuu, Aleksandr Klepinin, Vladimir A. Chekulayev, Natalja Timohhina, Kersti Tepp, Marju Puurand, Laura Truu, Karoliina Heck et al. · 2017 · Oxidative Medicine and Cellular Longevity
  27. Metabolomics in genetic testing
    Jacopo Troisi, Pierpaolo Cavallo, Angelo Colucci, Luca Pierri, Giovanni Scala, Steven J. K. Symes, Carter Jones, Sean M. Richards · 2020 · Advances in clinical chemistry
  28. Metabolic therapy and bioenergetic analysis: The missing piece of the puzzle
    Tomás Duraj, Josefa Carrión-Navarro, Thomas N. Seyfried, Noemí Garcia‐Romero, Ángel Ayuso‐Sacido · 2021 · Molecular Metabolism
  29. Immunometabolism in the tumor microenvironment and its related research progress
    Ziheng Zhang, Yajun Hu, Yuefeng Chen, Zhuoneng Chen, Yexin Zhu, Mingmin Chen, Jichu Xia, Yixuan Sun, Wenfang Xu · 2022 · Frontiers in Oncology
  30. Effect of pistachio kernel extracts in MCF-7 breast cancer cells: Inhibition of cell proliferation, induction of ROS production, modulation of glycolysis and of mitochondrial respiration
    Patricia Reboredo‐Rodríguez, Carmen González‐Barreiro, B. Cancho-Grande, Jesús Simal‐Gándara, Francesca Giampieri, Tamara Yuliett Forbes-Hernández, Massimiliano Gasparrini, Sadia Afrin, Danila Cianciosi, Piera Pia Manna et al. · 2018 · Journal of Functional Foods
  31. COX7A1 suppresses the viability of human non‐small cell lung cancer cells via regulating autophagy
    Lei Zhao, Xin Chen, Yetong Feng, Guangsuo Wang, Imran Nawaz, Li–Fu Hu, Pengfei Liu · 2019 · Cancer Medicine
  32. Crucial Residue Involved in L-Lactate Recognition by Human Monocarboxylate Transporter 4 (hMCT4)
    Shotaro Sasaki, Masaki Kobayashi, Yuya Futagi, Jiro Ogura, Hiroaki Yamaguchi, Natsuko Takahashi, Ken Iseki · 2013 · PLoS ONE
  33. Caveolin‐1 in oncogenic metabolic symbiosis
    Martina Raudenská, Jaromír Gumulec, Jan Balvan, Michal Masařík · 2020 · International Journal of Cancer
  34. A Small Molecule with Anticancer and Antimetastatic Activities Induces Rapid Mitochondrial-Associated Necrosis in Breast Cancer
    Anja Bastian, Jessica E. Thorpe, Bryan C. Disch, Lora C. Bailey‐Downs, Aleem Gangjee, Ravi Kumar Vyas Devambatla, Jim Henthorn, Kenneth Michael Humphries, Shraddha S. Vadvalkar, Michael A. Ihnat · 2015 · Journal of Pharmacology and Experimental Therapeutics
  35. Metaboloptics: Visualization of the tumor functional landscape via metabolic and vascular imaging
    Amy F. Martinez, Samuel Spence McCachren, Marianne Lee, Helen A. Murphy, Caigang Zhu, Brian T. Crouch, Hannah L. Martin, Alaattin Erkanli, Narasimhan Rajaram, Kathleen A. Ashcraft et al. · 2018 · Scientific Reports
  36. Co-regulated gene expression of splicing factors as drivers of cancer progression
    Esmee Koedoot, Marcel Smid, John A. Foekens, John W.M. Martens, Sylvia E. Le Dévédec, Bob van de Water · 2019 · Scientific Reports
  37. Potential Mechanism Underlying the Role of Mitochondria in Breast Cancer Drug Resistance and Its Related Treatment Prospects
    Yuefeng Li, Zhian Li · 2021 · Frontiers in Oncology
  38. Metabolic Interplay between Tumour Cells and Cancer-Associated Fibroblasts (CAFs) under Hypoxia versus Normoxia
    Septelia Inawati Wanandi, Sri Suciati Ningsih, Hijrah Asikin, Rendy Hosea, Gladies Mercya Grameinie Neolaka · 2018 · Malaysian Journal of Medical Sciences
  39. Metabolic and Amino Acid Alterations of the Tumor Microenvironment
    Petr Štěpka, Vít Všianský, Martina Raudenská, Jaromír Gumulec, Vojtěch Adam, Michal Masařík · 2020 · Current Medicinal Chemistry
  40. Monocarboxylate Transporter-1 (MCT1)-Mediated Lactate Uptake Protects Pancreatic Adenocarcinoma Cells from Oxidative Stress during Glutamine Scarcity Thereby Promoting Resistance against Inhibitors of Glutamine Metabolism
    Nourhane Ammar, Maya Hildebrandt, Claudia Geismann, Christian Röder, Timo Gemoll, Susanne Sebens, Anna Trauzold, H. Schäfer · 2023 · Antioxidants
  41. Metabolic control analysis of respiration in human cancer tissue
    Tuuli Käämbre, Vladimir A. Chekulayev, Igor N. Shevchuk, Kersti Tepp, Natalja Timohhina, Minna Varikmaa, Rafaela Bagur Quetglas, Aleksandr Klepinin, Tiia Anmann, Andre Koit et al. · 2013 · Frontiers in Physiology
  42. The crosstalking of lactate‐Histone lactylation and tumor
    Yao Rong, Fengyuan Dong, Guiqian Zhang, Mingzheng Tang, Xiashuang Zhao, Yan Zhang, Pengxian Tao, Hui Cai · 2023 · PROTEOMICS - CLINICAL APPLICATIONS
  43. miR-125b regulates differentiation and metabolic reprogramming of T cell acute lymphoblastic leukemia by directly targeting A20
    Zixing Liu, Kelly R. Smith, Hung T. Khong, Jingshan Huang, Eun-Young Erin Ahn, Ming Zhou, Ming Tan · 2016 · Oncotarget
  44. Evaluation of MDA-MB-468 Cell Culture Media Analysis in Predicting Triple-Negative Breast Cancer Patient Sera Metabolic Profiles
    Wojciech Wojtowicz, Anna Wróbel, Karolina Pyziak, Radosław Tarkowski, Alicja Balcerzak, Marek Bębenek, Piotr Młynarz · 2020 · Metabolites
  45. Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer
    Roberto Corchado‐Cobos, Natalia García‐Sancha, Marina Mendiburu‐Eliçabe, Aurora Gómez-Vecino, Alejandro Jiménez‐Navas, Manuel Jesús Pérez‐Baena, Marina Holgado-Madruga, Jian‐Hua Mao, Javier Cañueto, Sonia Castillo‐Lluva et al. · 2022 · Cancers
  46. Metabolism in the Tumor Microenvironment
    Francesca Montenegro, Stefano Indraccolo · 2020 · Advances in experimental medicine and biology
  47. Overcoming Therapy Resistance and Relapse in TNBC: Emerging Technologies to Target Breast Cancer-Associated Fibroblasts
    Farhana Mollah, Pegah Varamini · 2021 · Biomedicines
  48. Crosstalk between Immune Checkpoint Modulators, Metabolic Reprogramming and Cellular Plasticity in Triple-Negative Breast Cancer
    Arpita Poddar, Sushma R. Rao, Prashanth Prithviraj, George Kannourakis, Aparna Jayachandran · 2022 · Current Oncology
  49. Multicompartment metabolism in papillary thyroid cancer
    Joseph Curry, Patrick T. Tassone, Paolo Cotzia, John David Sprandio, Adam Luginbuhl, David M. Cognetti, Mehri Mollaee, Marina Domingo‐Vidal, Edmund A. Pribitkin, William M. Keane et al. · 2015 · The Laryngoscope
  50. Targeting Metabolic Cross Talk Between Cancer Cells and Cancer-Associated Fibroblasts
    Jin Gyoung Jung, Anne Le · 2021 · Advances in experimental medicine and biology
  51. Caveolae-Associated Molecules, Tumor Stroma, and Cancer Drug Resistance: Current Findings and Future Perspectives
    Jin‐Yih Low, Marikki Laiho · 2022 · Cancers
  52. Stromal-epithelial lactate shuttle induced by tumor‑derived interleukin‑1β promotes cell proliferation in oral squamous cell carcinoma
    Jie Wu, Yun Kyoung Hong, Tong Wu, Juan Wang, Xiaobing Chen, Zhi Wang, Bin Cheng, Juan Xia · 2017 · International Journal of Molecular Medicine
  53. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia
    Aline da Rocha Matos, Cláudia Malheiros Coutinho‐Camillo, Luiz Cláudio Santos Thuler, F.P. Fonseca, Fernando Augusto Soares, E.A. Silva, Etel Rodrigues Pereira Gimba · 2013 · Experimental and Molecular Pathology
  54. Metabolic signature of squamous cell carcinoma of the head and neck: Consequences of TP53 mutation and therapeutic perspectives
    Mark David Wilkie, Andrew Lau, Nikolina Vlatković, Terence M. Jones, Mark T. Boyd · 2018 · Oral Oncology
  55. Physical Exercise and Tumor Energy Metabolism
    Anderson Vulczak, Luciane C. Alberici · 2022 · Cancer Treatment and Research Communications
  56. High Monocarboxylate Transporter 4 Protein Expression in Stromal Cells Predicts Adverse Survival in Gastric Cancer
    Ping Yan, Yuhong Li, Zhijiao Tang, Xiang Shu, Xia Liu · 2014 · Asian Pacific Journal of Cancer Prevention
  57. Measuring relative utilization of aerobic glycolysis in breast cancer cells by positional isotopic discrimination
    Da‐Qing Yang, Dana M. Freund, B. Harris, Defeng Wang, Margot P. Cleary, Adrian D. Hegeman · 2016 · FEBS Letters
  58. Metabolic reprogramming and its clinical application in thyroid cancer (Review)
    Shishuai Wen, Tingting Zhang, Di-xin Xue, Wei-li Wu, Yulong Wang, Yu Wang, Qinghai Ji, Yongxue Zhu, Ning Qu, Rong‐Liang Shi · 2019 · Oncology Letters
  59. Molecular characterization of Gleason patterns 3 and 4 prostate cancer using reverse Warburg effect-associated genes
    Ilinca Georgescu, Robert J Gooding, R. Christopher Doiron, Andrew G. Day, Shamini Selvarajah, Chris Davidson, David Monty Berman, Paul C. Park · 2016 · Cancer & Metabolism
  60. The expression of metabolism-related proteins in phyllodes tumors
    Ji Eun Kwon, Woo-Hee Jung, Ja Seung Koo · 2012 · Tumor Biology
  61. Targeting Mitochondria for Cancer Treatment – Two Types of Mitochondrial Dysfunction
    Jiřı́ Pokorný, J. Pokorný, J Kobilková, A Jandová, Jan Vrba, Jan Vrba · 2014 · Prague Medical Report
  62. Thyroid Cancer Metabolism: A Review
    Kurren S. Gill, Patrick T. Tassone · 2016 · Journal of Thyroid Disorders & Therapy
  63. Expression of Monocarboxylate Transporter 1 Is Associated With Better Prognosis and Reduced Nodal Metastasis in Pancreatic Ductal Adenocarcinoma
    Aoi Sukeda, Yuka Nakamura, Yasunori Nishida, Motohiro Kojima, Naoto Gotohda, Tetsuo Akimoto, Atsushi Ochiai · 2019 · Pancreas
  64. Reverse Warburg: Straight to cancer
    Lorenzo Galluzzi, Oliver Kepp, Guido Kroemer · 2012 · Cell Cycle
  65. Loss of p53 in stromal fibroblasts promotes epithelial cell invasion through redox-mediated ICAM1 signal
    Dunyaporn Trachootham, Gang Chen, Wan Zhang, Weiqin Lu, Hui Zhang, Jinsong Liu, Peng Huang · 2013 · Free Radical Biology and Medicine
  66. Expression of Metabolism-Related Proteins in Lacrimal Gland Adenoid Cystic Carcinoma
    Ja Seung Koo, Jin Sook Yoon · 2015 · American Journal of Clinical Pathology
  67. The prognostic value of tumor-stroma proportion in laryngeal squamous cell carcinoma
    Mehtat Ünlü, Oğuz Çetinayak, Devrim Önder, Cenk Ecevit, Fadime Can Akman, Ahmet Ömer İkiz, Emel Ada, Bilge Karaçalı, Sülen Sarıoğlu · 2013 · Turkish Journal of Pathology
  68. Downregulation of cytochrome c oxidase subunit 7A1 expression is important in enhancing cell proliferation in adenocarcinoma cells
    Nawneet Mishra, Uddhav Timilsina, Dibya Ghimire, Ravi Chandra Dubey, Ritu Gaur · 2016 · Biochemical and Biophysical Research Communications
  69. In situ metabolic Characterisation of Breast Cancer and its Potential Impact on Therapy
    Petővári, Gábor, Dankó, Titanilla, Tőkés, Anna-Mária, Vetlényi, Enikő, Krencz, Ildikó, Raffay, Regina, Hajdu, Melinda, Sztankovics, Dániel, Németh, Krisztina, Vellai-Takács, Krisztina et al. · 2020 · Cancers
  70. The Expression of Glut-1, CAIX, and MCT4 in Mucinous Carcinoma
    Sewha Kim, Woo Hee Jung, Ja Seung Koo · 2013 · Journal of Breast Cancer
  71. HSF1: a mediator in metabolic alteration of hepatocellular carcinoma cells in cross-talking with tumor-associated macrophages.
    Hua Tian Liu, Dan Ai Huang, Miao Miao Li, He Deng Liu, Kun Guo · 2019 · Europe PMC (PubMed Central)
  72. Primed for cancer: Li Fraumeni Syndrome and the pre-cancerous niche
    Pan Pantziarka · 2015 · ecancermedicalscience
  73. A New and Integral Approach to the Etiopathogenesis and Treatment of Breast Cancer Based upon Its Hydrogen Ion Dynamics
    Salvador Harguindey, Khalid Omer Alfarouk, Julian David Polo Orozco, Kévin Hardonnière, Daniel Stanciu, Stefano Fais, Jesús Devesa · 2020 · International Journal of Molecular Sciences
  74. When fat becomes an ally of the enemy: adipose tissue as collaborator in human breast cancer
    Lore Lapeire, Hannelore G Denys, Véronique Cocquyt, Olivier De Wever · 2015 · Hormone Molecular Biology and Clinical Investigation
  75. Dynamic Interplay in Tumor Ecosystems: Communication between Hepatoma Cells and Fibroblasts
    Gábor Petővári, Gábor Tóth, Lilla Turiák, Anna L. Kiss, Krisztina Pálóczi, Anna Réka Sebestyén, Adrián Pesti, András Kiss, Kornélia Baghy, Katalin Dezső et al. · 2023 · International Journal of Molecular Sciences
  76. Expression of caveolin-1 in breast cancer stroma as a potential prognostic biomarker of survival and progression: a meta-analysis
    Xiuying Li, Jinfan Sun, Shuenqin Hu · 2017 · Wiener klinische Wochenschrift
  77. Breast cancer fibroblasts and cross-talk
    Priyanila Magesh, Sanu Thankachan, Thejaswini Venkatesh, Padmanaban S. Suresh · 2021 · Clinica Chimica Acta
  78. La tumeur cancéreuse : un parasite métabolique ?
    Philippe Icard, Hubert Lincet · 2013 · Bulletin du Cancer
  79. Stromal glycolysis and MCT4 are hallmarks of DCIS progression to invasive breast cancer
    Michael P. Lisanti, Federica Sotgia, Richard G. Pestell, Anthony Howell, Ubaldo Martinez‐Outschoorn · 2013 · Cell Cycle
  80. Lactate metabolic pathway regulates tumor cell metastasis and its use as a new therapeutic target
    Weimei Xing, Xiaowei Li, Yuli Zhou, Mengsen Li, Mingyue Zhu · 2023 · Exploration of Medicine
  81. Dissecting the multifaceted roles of autophagy in cancer initiation, growth, and metastasis: from molecular mechanisms to therapeutic applications
    Afia Ayub, Md. Kamrul Hasan, Zimam Mahmud, Md. Sabbir Hossain, Yearul Kabir · 2024 · Medical Oncology
  82. Cellular and humoral immunodeficiency in breast cancer patients resistant to hormone therapy
    Eva Závadová, Michal Vočka, Jiří Špaček, Bohuslav Konopásek, T Fučíková, Lubos B. Petruzelka · 2013 · Neoplasma
  83. Mis‐estimation and bias of hyperpolarized apparent diffusion coefficient measurements due to slice profile effects
    Jeremy W. Gordon, Eugene Milshteyn, Irene Marco‐Rius, Michael A. Ohliger, Daniel B. Vigneron, Peder E. Z. Larson · 2016 · Magnetic Resonance in Medicine
  84. Expression of Autophagy-Related Proteins According to Androgen Receptor and HER-2 Status in Estrogen Receptor-Negative Breast Cancer
    Ji-Ye Kim, Woo Hee Jung, Ja Seung Koo · 2014 · PLoS ONE
  85. Triple negative breast cancer: the role of metabolic pathways.
    Sarah Dean, Anthony Rhodes · 2014 · PubMed
  86. Physiological effects of bean (Phaseolus vulgarisL.) consumption on cellular signaling in cancer
    Matthew D. Thompson, Henry J. Thompson · 2012 · Cell Cycle
  87. Monocarboxylate Transporter 4 in Cancer-Associated Fibroblasts Is a Driver of Aggressiveness in Aerodigestive Tract Cancers
    Marina Domingo‐Vidal, Diana Whitaker‐Menezes, Mehri Mollaee, Zhao Lin, Madalina Tuluc, Nancy J. Philp, Jennifer Maria Johnson, Tingting Zhan, Joseph Curry, Ubaldo Martinez‐Outschoorn · 2022 · Frontiers in Oncology
  88. NRF1 Regulates the Epithelial Mesenchymal Transition of Breast Cancer by Modulating ROS Homeostasis
    Linjuan Sun, Nan Ouyang, Shaheryar Shafi, Rongchuan Zhao, Jinlin Pan, Lei Hong, Xueyan Song, Xiaohan Sa, Yuanshuai Zhou · 2023 · Technology in Cancer Research & Treatment
  89. Inhibition of energy metabolism by 3-bromopyruvate in the hard tick Rhipicephalus microplus
    Valdir Braz, Helga Gomes, Antônio Galina, Luiz Saramago, Glória Regina Cardoso Braz, Itabajara da Silva Vaz, Carlos Logullo, Rodrigo Nunes da Fonseca, Eldo Campos, Jorge Moraes · 2018 · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology
  90. Reverse Warburg Effect-Related Mitochondrial Activity and 18F-FDG Uptake in Invasive Ductal Carcinoma
    Byung Wook Choi, Young Ju Jeong, Sung Hwan Park, Hoon Kyu Oh, Sung Min Kang · 2019 · Nuclear Medicine and Molecular Imaging
  91. Metabolic Reprogramming in Thyroid Cancer: Role of the Epithelial-Mesenchymal Transition
    Monica Fedele, Sabrina Battista, Laura Cerchia · 2021 · Endocrines
  92. Contribution of pH Alterations to the Tumor Microenvironment
    Angela Strambi, Angelo De Milito · 2015 · Springer eBooks
  93. Expression of Cav-1, MCT1, and MCT4 in Ductal Carcinoma In Situ of the Breast and Their Associations With Clinicopathologic Features
    Nah Ihm Kim, Min Ho Park, Ji Shin Lee · 2023 · Applied immunohistochemistry & molecular morphology
  94. Identifying cancer subtypes based on embryonic and hematopoietic stem cell signatures in pan-cancer
    Jiali Lei, Jiangti Luo, Qian Liu, Xiaosheng Wang · 2023 · Cellular Oncology
  95. Mitophagy and Reverse Warburg Effect: Metabolic Compartmentalization of Tumor Microenvironment
    Prajna Paramita Naik · 2020 · Springer eBooks
  96. Expression of Glucose Metabolism-Related Proteins in Adrenal Neoplasms
    Eun‐Kyung Kim, Hye Min Kim, Ja Seung Koo · 2021 · Pathobiology
  97. RETRACTED: Physical activity and glioblastoma: a paradigm shift in neuro-oncology therapy
    Lin Xie, Feng Wang · 2025 · Frontiers in Oncology · Retracted
  98. New approaches to radio- and chemosensitization using proton pump inhibitors through the lens of tumor cell microenvironment patterns
    Fedir Volodymyrovych Hladkykh, H.V. Kulinich, T.G. Zolotarova · 2023 · Український радіологічний та онкологічний журнал
  99. Expression of reactive oxygen species-related proteins in metastatic breast cancer is dependent on the metastatic site.
    Hye Min Kim, Woo Hee Jung, Ja Seung Koo · 2014 · Europe PMC (PubMed Central)
  100. Immunity or morphogenesis in cancer development and treatment
    Aleksei N. Shoutko · 2019 · Integrative Cancer Science and Therapeutics